Spots Global Cancer Trial Database for gw786034
Every month we try and update this database with for gw786034 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors | NCT01454804 | Advanced Cancer... | Pazopanib Lapatinib Trastuzumab (He... Pazopanib | - | M.D. Anderson Cancer Center | |
| GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma | NCT00244764 | Carcinoma, Rena... | GW786034 Placebo | 21 Years - | GlaxoSmithKline | |
| Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer | NCT01548144 | Advanced Cancer... | Crizotinib (Xal... Pazopanib Pemetrexed | 18 Years - | M.D. Anderson Cancer Center | |
| Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors | NCT01956669 | Solid Tumours | Pazopanib | 1 Year - 18 Years | Novartis | |
| Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer | NCT01548144 | Advanced Cancer... | Crizotinib (Xal... Pazopanib Pemetrexed | 18 Years - | M.D. Anderson Cancer Center | |
| Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors | NCT01454804 | Advanced Cancer... | Pazopanib Lapatinib Trastuzumab (He... Pazopanib | - | M.D. Anderson Cancer Center | |
| Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors | NCT01956669 | Solid Tumours | Pazopanib | 1 Year - 18 Years | Novartis | |
| Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | NCT00558103 | Neoplasms, Brea... | lapatinib Pazopanib | 18 Years - | GlaxoSmithKline | |
| Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer | NCT00367679 | Non-Small Cell ... Lung Cancer, No... | Pazopanib | 21 Years - | GlaxoSmithKline | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| Phase II Study of Pazopanib and Topotecan in Cervical Cancer | NCT02348398 | Cervical Cancer | Pazopanib Topotecan Phone Call | 18 Years - | M.D. Anderson Cancer Center | |
| Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma | NCT00256880 | Carcinoma, Rena... | GW786034 | 21 Years - | GlaxoSmithKline | |
| Study To Assess Long Term Safety Of Pazopanib | NCT00387205 | Carcinoma, Rena... | Pazopanib | 18 Years - | Novartis | |
| Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer | NCT00866528 | Lung Cancer, No... | pazopanib paclitaxel | 18 Years - | GlaxoSmithKline | |
| Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors | NCT01454804 | Advanced Cancer... | Pazopanib Lapatinib Trastuzumab (He... Pazopanib | - | M.D. Anderson Cancer Center | |
| Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer | NCT00871403 | Lung Cancer, No... | pazopanib and p... pemetrexed and ... | 18 Years - | GlaxoSmithKline | |
| Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma | NCT00256880 | Carcinoma, Rena... | GW786034 | 21 Years - | GlaxoSmithKline | |
| Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer | NCT00866528 | Lung Cancer, No... | pazopanib paclitaxel | 18 Years - | GlaxoSmithKline | |
| Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma | NCT00334282 | Carcinoma, Rena... | Pazopanib placebo | 18 Years - | GlaxoSmithKline | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer | NCT00615524 | Hormone-recepto... | exemestane and ... | 18 Years - | GlaxoSmithKline | |
| Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients | NCT00158782 | Carcinoma, Rena... | GW786034 lapatinib | 21 Years - | GlaxoSmithKline | |
| Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial | NCT01217931 | Kidney Cancer | Pazopanib Bevacizumab Everolimus | 18 Years - | M.D. Anderson Cancer Center | |
| Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | NCT00558103 | Neoplasms, Brea... | lapatinib Pazopanib | 18 Years - | GlaxoSmithKline | |
| Study To Assess Long Term Safety Of Pazopanib | NCT00387205 | Carcinoma, Rena... | Pazopanib | 18 Years - | Novartis | |
| Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors | NCT01454804 | Advanced Cancer... | Pazopanib Lapatinib Trastuzumab (He... Pazopanib | - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
